The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus

Diabetologia

Volumn 56, Issue 5, 2013, Pages 1166-1173

  Har, R ^a   Scholey, J W ^a   Daneman, D ^b   Mahmud, F H ^b   Dekker, R ^b   Lai, V ^a   Elia, Y ^b   Fritzler, M L ^c   Sochett, E B ^b   Reich, H N ^a   Cherney, D Z I ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Eve Technologies   (Canada)

Author keywords

Renal hyperfiltration; Type 1 diabetes; Urine cytokines chemokines

Indexed keywords

ALPHA2 INTERFERON; CD40 ANTIGEN; CHEMOKINE; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RANTES;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN INTAKE; RENAL HYPERFILTRATION; SODIUM INTAKE; URINARY EXCRETION;

ADULT; BIOLOGICAL MARKERS; CHEMOKINES; COHORT STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION BARRIER; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMANS; MALE; PILOT PROJECTS; RENAL CIRCULATION; SEVERITY OF ILLNESS INDEX; UP-REGULATION; YOUNG ADULT;

EID: 84876500065     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2857-5     Document Type: Article

References (47)

1. Riser BL, Varani J, Cortes P, Yee J, Dame M, Sharba AK (2001) Cyclic stretching of mesangial cells up-regulates intercellular adhesion molecule-1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am J Pathol 158:11-17
2. Sayyed SG, Hagele H, Kulkarni OP, et al.(2009) Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 52:2445-2454
3. Sayyed SG, Ryu M, Kulkarni OP, et al.(2011) An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int 80:68-78
4. Yamagishi S, Inagaki Y, Okamoto T, et al.(2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277:20309-20315
5. Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV (2010) Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain 11:360-368
6. Cherney DZ, Scholey JW, Sochett E, Bradley TJ, Reich HN (2011) The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care 34:177-180
7. Cherney DZI, Scholey JW, Daneman D, et al.(2012) Urinary markers of renal inflammation in adolescents with type 1 diabetes mellitus and normoalbuminuria. Diabet Med 29:1297-1302
8. Wolkow PP, Niewczas MA, Perkins B, et al.(2008) Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol 19:789-797
9. Cherney DZ, Scholey JW, Miller JA (2008) Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev 4:280-290
10. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG (2009) Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691-697
11. Cherney DZ, Reich HN, Jiang S, et al.(2012) Hyperfiltration and the effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 303:R710-R718
12. Cherney DZ, Sochett EB (2011) Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes. Diabetes Care 34:1821-1826
13. Cherney DZ, Miller JA, Scholey JW, et al.(2008) The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 57:688-695
14. Davidson WD, Sackner MA (1963) Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 62:351-356
15. Jung K, Klotzek S, Schulze BD (1990) Refinements of assays for low concentrations of inulin in serum. Nephron 54:360-361
16. Florijn KW, Barendregt JN, Lentjes EG, et al.(1994) Glomerular filtration rate measurement by «single-shot» injection of inulin. Kidney Int 46:252-259
17. Cherney DZ, Miller JA, Scholey JW, et al.(2010) Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care 33:1344-1346
18. Perkins BA, Sochett EB, Cherney DZ (2012) Ability of cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. Clin Exp Hypertens 34:606-611
19. Cherney DZ, Sochett EB, Dekker MG, Perkins BA (2010) Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated type 1 diabetes. Diabet Med 27:1358-1365
20. Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294:F697-F701
21. Takebayashi K, Suetsugu M, Matsumoto S, Aso Y, Inukai T (2009) Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia. South Med J 102:361-368
22. Ye SD, Zheng M, Zhao LL, et al.(2009) Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy. Eur J Clin Invest 39:980-985
23. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA (2012) The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 97:4383-4389
24. Sasson AN, Cherney DZ (2012) Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes 3:1-6
25. Vallon V, Wead LM, Blantz RC (1995) Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. J Am Soc Nephrol 5:1761-1767
26. Montanari A, Biggi A, Cabassi A, et al.(2012) Renal hemodynamic response to L-arginine in uncomplicated, type 1 diabetes mellitus: the role of buffering anions and tubuloglomerular feedback. Am J Physiol Renal Physiol 303:F648-F658
27. Bank N, Aynedjian HS (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312
28. Vallon V, Thomson SC (2012) Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74:351-375
29. Thomas MC, Moran JL, Harjutsalo V, et al.(2012) Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia 55:1505-1513
30. Noh H, Ha H, Yu MR, et al.(2002) High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron 90:78-85
31. Sasaki M, Shikata K, Okada S, et al.(2011) The macrophage is a key factor in renal injuries caused by glomerular hyperfiltration. Acta Med Okayama 65:81-89
32. Ichinose K, Maeshima Y, Yamamoto Y, et al.(2005) Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54:2891-2903
33. Merchant ML, Perkins BA, Boratyn GM, et al.(2009) Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 20:2065-2074
34. Gilbert RE, Kim SA, Tuttle KR, et al.(2007) Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes. Diabetes Care 30:995-996
35. Andersen S, van Nieuwenhoven FA, Tarnow L, et al.(2005) Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 67:2325-2329
36. Tashiro K, Koyanagi I, Saitoh A, et al.(2002) Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 16:1-4
37. Cherney DZ, Konvalinka A, Zinman B, et al.(2009) Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care 32:91-93
38. Dzurik R, Pontuch P, Spustova V (1997) Modulators and mediators of kidney disease progression: new targets of prevention and treatment. Bratisl Lek Listy 98:663-666
39. Cohen-Bucay A, Viswanathan G (2012) Urinary markers of glomerular injury in diabetic nephropathy. Int J Nephrol 2012:146987
40. Ruster C, Wolf G (2008) The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 13:944-955
41. Mezzano S, Aros C, Droguett A, et al.(2004) NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19:2505-2512
42. Mezzano S, Droguett A, Burgos ME,, et al.(2003) Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl (86):S64-S70
43. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA (2006) Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 17:1703-1709
44. Mauer M, Zinman B, Gardiner R, et al.(2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361:40-51
45. Halimi JM (2012) The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes Metab 38:291-297
46. Perkins BA, Krolewski AS (2009) Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens 18:233-240
47. Miller JA (1997) Renal responses to sodium restriction in patients with early diabetes mellitus. J Am Soc Nephrol 8:749-755